13.07.2015 Views

vol21no7_pdf-version

vol21no7_pdf-version

vol21no7_pdf-version

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

LETTERSprovinces and a total of 200 camels. Umnogovi Provincehas the largest, and Dundgovi Province the fifth largest,camel population in the country (≈113,000 and ≈28,000animals, respectively). Further studies on the epidemiologyof MERS-CoV infection in dromedaries and Bactriancamels from central Asia, China, and Mongolia are warranted.The field work for this study was supported by a researchgrant from The University of Hong Kong; the laboratorytesting was supported by the National Institutes of Health,National Institute of Allergy and Infectious Diseases (contractN272201400006C).References1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME,Fouchier RAM. Isolation of a novel coronavirus from a man withpneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814–20.http://dx.doi.org/10.1056/NEJMoa12117212. World Health Organization. Middle East respiratory syndromecoronavirus (MERS-CoV): summary of current situation, literatureupdate and risk assessment–as of 5 February 2015 [cited 2015 Feb25]. http://www.who.int/csr/disease/coronavirus_infections/mers-5-february-2015.<strong>pdf</strong>?ua=13. Reusken CBEM, Haagmans BL, Müller MA, Gutierrez C,Godeke G-J, Meyer B, et al. Middle East respiratory syndromecoronavirus neutralising serum antibodies in dromedary camels: acomparative serological study. Lancet Infect Dis. 2013;13:859–66.http://dx.doi.org/10.1016/S1473-3099(13)70164-64. Chan RWY, Hemida MG, Kayali G, Chu DKW, Poon LLM,Alnaeem A, et al. Tropism and replication of Middle Eastrespiratory syndrome coronavirus from dromedary camels inthe human respiratory tract: an in-vitro and ex-vivo study.Lancet Respir Med. 2014;2:813–22. http://dx.doi.org/10.1016/S2213-2600(14)70158-45. Azhar EI, El-Kafrawy SA, Farraj SA, Hassan AM, Al-Saeed MS,Hashem AM, et al. Evidence for camel-to-human transmission ofMERS coronavirus. N Engl J Med. 2014;370:2499–505.http://dx.doi.org/10.1056/NEJMoa14015056. Reusken CBEM, Messadi L, Feyisa A, Ularamu H, Godeke G-J,Danmarwa A, et al. Geographic distribution of MERScoronavirus among dromedary camels, Africa. Emerg Infect Dis.2014;20:1370–4. http://dx.doi.org/10.3201/eid2008.1405907. Chu DKW, Poon LLM, Gomaa MM, Shehata MM,Perera RAPM, Abu Zeid D, et al. MERS coronaviruses indromedary camels, Egypt. Emerg Infect Dis. 2014;20:1049–53.http://dx.doi.org/10.3201/eid2006.1402998. Hemida MG, Perera RA, Al Jassim RA, Kayali G, Siu LY,Wang P, et al. Seroepidemiology of Middle East respiratorysyndrome (MERS) coronavirus in Saudi Arabia (1993) andAustralia (2014) and characterisation of assay specificity.Euro Surveill. 2014;19: pii 20828.9. Wang N, Shi X, Jiang L, Zhang S, Wang D, Tong P, et al.Structure of MERS-CoV spike receptor-binding domaincomplexed with human receptor DPP4. Cell Res. 2013;23:986–93.http://dx.doi.org/10.1038/cr.2013.92Address for correspondence: Malik Peiris, School of Public Health,The University of Hong Kong, 21 Sassoon Rd, Pokfulam, Hong KongSpecial Administrative Region, China; email: malik@hku.hkOligella ureolyticaBacteremia in Elderly Woman,United StatesTristan Simmons, Eryn Fennelly, David LoughranAuthor affiliation: Philadelphia College of Osteopathic Medicine,Philadelphia, Pennsylvania, USADOI: http://dx.doi.org/10.3201/eid2107.150242To the Editor: Oligella ureolytica is an aerobic gramnegativecoccobacillus found as a commensal organism inhuman urinary tracts (1). Previously referred to as CDCGroup IVe, this bacterium is not commonly encounteredas a source of infection and is difficult to isolate by usingconventional laboratory procedures (2). The few cases ofpathogenic infection with O. ureolytica described in the literaturehave occurred in patients ranging in age from newbornto 89 years and from the varied locations of India,Turkey, Canada, and the United States (3–7). We report acase of O. ureolytica bacteremia in a patient in whom sepsiswas diagnosed and review the current literature on thisemerging pathogen.A 66-year-old woman sought treatment in our emergencydepartment for a fever of 100.7°F, femur fracture,and a right buttock stage III decubitus ulcer. She reportedhaving fallen 4 days earlier, after which she was unable towalk and spent 4 days laying in her own urine and feces.Blood tests revealed an elevated leukocyte count of 24.4× 10 9 cells/L (76% neutrophils, 2% bands), and urinalysisshowed trace leukocyte esterase, +3 bacteria, and 5–10 leukocytes.Chest radiograph and head computed tomographyimages were unremarkable. Her electrocardiogram showednonspecific ST wave changes. Samples from the patient’sblood, urine, and wounds were collected while the patientwas in the emergency department and were sent for culture.Wound cultures showed growth of Proteus mirabilisand Enterococcus spp. The urine culture grew >100,000CFU Escherichia coli. The first set of blood culturesgrew O. ureolytica in aerobic and anaerobic bottles, butanother set drawn 30 min later showed no growth. Theblood cultures were processed by using the Bact/Alert 3D(bioMérieux, Marcy l’Etoile, France) and Gram stained.Identification was from the Vitek 2 compact system (bio-Mérieux). The O. ureolytica sample was sensitive to amikacin,ampicillin/sulbactam, ceftazidime, ceftriaxone,gentamicin, imipenem, levofloxacin, nitrofurantoin, trimethoprim/sulfamethoxazole,and chloramphenicol. Noresistance was found.Because of the unique bacteremia, further diagnosticswere conducted. The results of chest, abdomen, and pelviccomputed tomography scans were unremarkable. HIVEmerging Infectious Diseases • www.cdc.gov/eid • Vol. 21, No. 7, July 2015 1271

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!